Page last updated: 2024-11-04

sulfasalazine and Giant Cell Arteritis

sulfasalazine has been researched along with Giant Cell Arteritis in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Giant Cell Arteritis: A systemic autoimmune disorder that typically affects medium and large ARTERIES, usually leading to occlusive granulomatous vasculitis with transmural infiltrate containing multinucleated GIANT CELLS. The TEMPORAL ARTERY is commonly involved. This disorder appears primarily in people over the age of 50. Symptoms include FEVER; FATIGUE; HEADACHE; visual impairment; pain in the jaw and tongue; and aggravation of pain by cold temperatures. (From Adams et al., Principles of Neurology, 6th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harada, S1
Mitsunobu, F1
Kodama, F1
Hosaki, Y1
Mifune, T1
Tsugeno, H1
Okamoto, M1
Yamamura, M1
Makino, H1
Tanizaki, Y1

Other Studies

1 other study available for sulfasalazine and Giant Cell Arteritis

ArticleYear
Giant cell arteritis associated with rheumatoid arthritis monitored by magnetic resonance angiography.
    Internal medicine (Tokyo, Japan), 1999, Volume: 38, Issue:8

    Topics: Anti-Inflammatory Agents; Arthritis, Juvenile; Arthritis, Rheumatoid; Female; Giant Cell Arteritis;

1999